Skip to main content
Equibles
STOK logo

STOK · Stoke Therapeutics, Inc. · Analyst Estimates

Track STOK — free

Use STOK with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research STOK.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$29.34 -0.58 (-1.94%) At close · Sep 10
Russell 2000 member Rebalance outlook locked
Market Cap
$1.93B
Shares
64.53M

Analyst Estimates

Compare analyst forecasts for Stoke Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Only independently verified consensus published through the company's investor-relations sources is available.

Consensus not yet available

Only independently verified consensus published through the company's investor-relations sources is available.

Key facts CIK 1623526 CUSIP 86150R107 13F (30d) 125 filings 124 filers Visit website Investor relations